effects [qlco]
Androgens [horm, phsu]
Haemostasis [ortf]
Androgen deficiency [dsyn]
Associated [qlco]
Increased [qnco]
Incidence [qnco]
Cardiovascular disease [dsyn]
Evidence [ftcn]
Thromboembolic disease [dsyn]
Myocardial Infarction [dsyn]
Males [fndg]
mediated [socb]
low [qlco]
baseline [bodm]
fibrinolytic [topp]
activity [dora]
Hypogonadism [dsyn]
Males [fndg]
Associated [qlco]
Enhancement [topp]
fibrinolytic [topp]
Inhibition [menp]
Increased [qnco]
synthesis [biof]
Pai [idcn]
Hand [bpoc]
Stanozolol [horm, phsu, strd]
Danazol [horm, phsu, strd]
Associated [qlco]
increased activity [fndg]
fibrinolytic [topp]
Male [fndg]
Anabolic steroids [phsu, strd]
Reticular [spco]
Effect [qlco]
haemostatic [ortf]
System [ftcn]
Change [ftcn]
APPEAR [qlco]
To [qlco]
Individual [popg]
Threshold [qlco]
Dose [qnco]
effects [qlco]
Platelets [cell]
vasomotion [ortf]
Overcome [acty]
effects [qlco]
Numerous [qnco]
Reports [inpr]
weight lifters [prog]
dying [orgf]
ischaemic heart disease [dsyn]
Abuse [fndg]
Anabolic steroids [phsu, strd]
Androgens [horm, phsu]
Known [qlco]
To [qlco]
Profound [qlco]
effects [qlco]
Carbohydrate [carb]
Lipid Metabolism [moft]
Individual [popg]
Inconsistent [qlco]
effects [qlco]
Androgens [horm, phsu]
fibrinolytic [topp]
haemostatic [ortf]
activity [dora]
APPEAR [qlco]
To [qlco]
Based [ftcn]
Close [ftcn]
Metabolic [ftcn]
System [ftcn]
Androgens [horm, phsu]
Unfavorable [qlco]
effects [qlco]
HDL/cholesterol ratio [lbpr]
Triglyceride level [lbtr]
System [ftcn]
Hypertriglyceridaemia [fndg]
Insulin Resistance [patf]
Associated [qlco]
low [qlco]
fibrinolytic [topp]
activity [dora]
Increased [qnco]
Level [qlco]
Hand [bpoc]
Lipoprotein (a) [aapp, bacs]
Recently [tmco]
Independent [idcn]
Risk factor [qnco]
CVD, NOS [dsyn]
Show [inpr]
To [qlco]
Favorable [qlco]
Androgen [horm, phsu]
treatment [ftcn]
Men [popg]
Women [popg]
Women [popg]
agonists [phsu]
Antagonist [ortf]
effects [qlco]
Estrogens [horm, phsu, strd]
Progestins [horm, phsu, strd]
Need [qlco]
To [qlco]
Taken [cnce]
account [idcn]
Estradiol [horm, phsu, strd]
modulate [spco]
Testosterone [horm, phsu, strd]
effects [qlco]
Haemostasis [ortf]
Androgen [horm, phsu]
Medication [phsu]
premenopausal [tmco]
Women [popg]
Danazol [horm, phsu, strd]
Found [qnco]
To [qlco]
Suggest [idcn]
Improvement [cnce]
fibrinolytic [topp]
activity [dora]
Hormone replacement therapy [topp]
Androgen [horm, phsu]
Progestins [horm, phsu, strd]
Complex [qlco]
Compound [qlco]
Androgen Effects [phsf]
Associated [qlco]
Marked [qlco]
reduction [npop]
Improvement [cnce]
fibrinolytic [topp]
activity [dora]
Further [spco]
Improvement [cnce]
fibrinolytic [topp]
activity [dora]
Associated [qlco]
Marked [qlco]
Decrease [qlco]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Women [popg]
androgen replacement therapy [topp]
Hormone [horm]
Little NOS [cgab, dsyn]
Known [qlco]
Estrogens [horm, phsu, strd]
Progesterone derivative [horm, strd]
Testosterone [horm, phsu, strd]
IMPACT [gngm]
Metabolic [ftcn]
haemostatic [ortf]
Reticular [spco]
effects [qlco]
Preparation [ftcn]
summary [inpr]
Information [idcn]
effects [qlco]
Androgens [horm, phsu]
Haemostasis [ortf]
Limited [ftcn]
Incomplete [qnco]
Interaction [ftcn]
Sex [orgf]
Steroids [strd]
APPEAR [qlco]
To [qlco]
Case [ftcn]
Numerous [qnco]
effects [qlco]
Androgens, Synthetic [horm, phsu]
synthesis [biof]
Release [hlca]
haemostatic [ortf]
Factor [ftcn]
Increase [ftcn]
inhibitors [chvf]
Coagulation [ortf]
Decrease [qlco]
Inhibitor [qlco]
fibrinolytic [topp]
System [ftcn]
Androgens [horm, phsu]
Patients [podg]
Congenital deficiency [cgab]
Coagulation Factors [aapp, bacs, phsu]
Previous [tmco]
Events [evnt]
Cardiovascular disease [dsyn]
Result [ftcn]
Hand [bpoc]
reduction [npop]
fibrinolytic [topp]
Inhibition [menp]
Lp(a) [aapp, bacs]
considered [idcn]
Favorable [qlco]
effects [qlco]
Androgens [horm, phsu]
Risk [qlco]
Cardiovascular disease [dsyn]
Preparation [ftcn]
Androgen [horm, phsu]
effects [qlco]
Effect [qlco]
Combined [qlco]
Preparation [ftcn]
Need [qlco]
To [qlco]
Study [mnob]
More [ftcn]
Detail [qlco]
effects [qlco]
Androgens [horm, phsu]
Interest [menp]
Favorable [qlco]
effects [qlco]
Hormone replacement therapy [topp]
Cardiovascular disease [dsyn]
